Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to... see more

GREY:TBPMQ - Post Discussion

Tetra Bio Pharma Inc > QIXLEEF vs opioid
View:
Post by Golddetector on Jun 01, 2022 7:45am

QIXLEEF vs opioid

Recently published data on page 12 of phase 2 fda reborn trial showed at 30 minutes 34% QIXLEEF vs 38% opioid at 60minutes 65% QIXLEEF vs 66% opioid. These results are groundbreaking. It is against the most severe cancer pain that mean it can be used as alternative for everything else. The results also showed way more safety record. 

User image

Comment by JohnnyRingo20 on Jun 01, 2022 9:18am
  that's great and all. Only phase two? What's that than? Another 2 years before they apply?   be lucky to fund the next few months let alone year(s). 
Comment by Golddetector on Jun 01, 2022 10:23am
It is a big deal otherwise why the biggest cannabis trial setup in Australia is investing 7.5M in this trial. The drug evaluation is dependent on the success of each phase of the trial and it won't wait for all phases to complete to realize full value. We are talking about opioid alternative here. What will be the price tag on it. It is definitely 10 digits number
Comment by NSX001 on Jun 01, 2022 11:01am
Hi Gold, I fully agree with you on your post. The value attributed to QIXLEEF once phase II is complete will show that the sky is the limit. A ten digit valuation will be a given considering the likes of other deals done recently. The fact that all opiods will be negatively reviewed by all levels of Governments around the world will make QIXLEEF the go to pain drug. There WILL surely ...more  
Comment by Golddetector on Jun 01, 2022 3:24pm
Let's see QIXLEEF trials in Australia. They have to start that soon otherwise they won't get the money. In away the deal is good as it forces Tbp management to perform to get the money. Expect news soon regarding that. Not to mention Reduvo that might happen anytime now.
Comment by Savage97 on Jun 01, 2022 4:38pm
QIXLEEF will win vs opioids, and TBP will continue proving doubters wrong.   Long & Strong!!!!!!!!!!!!!!!!!GLTA!!!!!!!!!!!!!!!!!!!!
Comment by Normandt1965 on Jun 01, 2022 10:11am
Nice, thanks for the infos Goldetector!
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities